Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent

Journal of Virology

Volumn 82, Issue 13, 2008, Pages 6150-6160

  MacNamara, Katherine C ^a,b   Bender, Susan J ^a   Ming, Ming Chua ^a   Watson, Richard ^a   Weiss, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORONAVIRUS; CYTOKINE PRODUCTION; FLOW CYTOMETRY; LISTERIA MONOCYTOGENES; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; VIRUS ENCEPHALITIS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CORONAVIRUS INFECTIONS; FLOW CYTOMETRY; LYMPH NODES; MICE; MURINE HEPATITIS VIRUS; SPECIES SPECIFICITY;

MURINE HEPATITIS VIRUS; MUS;

EID: 45749157611     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00106-08     Document Type: Article

References (43)

1. Barthold, S. W., and A. L. Smith. 1992. Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice. Arch. Virol. 122:35-44.
2. Benn, S. C., and C. J. Woolf. 2004. Adult neuron survival strategies - slamming on the brakes. Nat. Rev. Neurosci. 5:686-700.
3. Bergmann, C. C., B. Parra, D. R. Hinton, R. Chandran, M. Morrison, and S. A. Stohlman 2003. Perforin-mediated effector function within the central nervous system requires IFN-γ-mediated MHC up-regulation. J. Immunol. 170:3204-3213.
4. Brändle, D., K. Burki, V. A. Wallace, U. H. Rohrer, T. W. Mak, B. Malissen, H. Hengartner, and H. Pircher. 1991. Involvement of both T cell receptor Vα and Vβ variable region domains and α chain junctional region in viral antigen recognition. Eur. J. Immunol. 21:2195-2202.
5. Buchmeier, M. J., H. A. Lewicki, P. J. Talbot, and R. L. Knobler. 1984. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132:261-270.
6. + T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants. J. Virol. 78:1150-1159.
7. Dalziel, R. G., P. W. Lampert, P. J. Talbot, and M. J. Buchmeier. 1986. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59:463-471.
8. Fazakerley, J. K., S. E. Parker, F. Bloom, and M. J. Buchmeier. 1992. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology 187:178-188.
9. Godfraind, C., K. V. Holmes, and J. P. Coutelier. 1995. Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice. J. Virol. 69:6541-6547.
10. + T cells. Microb. Pathog. 18:211-221.
11. Gordon, L. B., P. M. Knopf, and H. F. Cserr. 1992. Ovalbumin is more immunogenic when introduced into brain or cerebrospinal fluid than into extracerebral sites. J. Neuroimmunol. 40:81-87.
12. + T cells in the peripheral interfollicular region of lymph nodes. Nat. Immunol. 9:155-165.
13. Hingley, S. T., J. L. Gombold, E. Lavi, and S. R. Weiss. 1994. MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology 200:1-10.
14. Iacono, K. T., L. Kazi, and S. R. Weiss. 2006. Both spike and background genes contribute to murine coronavirus neurovirulence. J. Virol. 80:6834-6843.
15. Karman, J., C. Ling, M. Sandor, and Z. Fabry. 2004. Initiation of immune responses in brain is promoted by local dendritic cells. J. Immunol. 173: 2353-2361.
16. + T cells into the nervous system following ocular herpes simplex virus-1 infection. J. Immunol. 174:2919-2925.
17. Lavi, E., D. H. Gilden, Z. Wroblewska, L. B. Rorke, and S. R. Weiss. 1984. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34:597-603.
18. Lavi, E., A. Suzumura, M. Hirayama., M. K. Highkin, D. M. Dambach, D. H. Silberberg, and S. R. Weiss. 1987. Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microb. Pathog. 3:79-86.
19. Ling, C., M. Sandor, and Z. Fabry. 2003. In situ processing and distribution of intracerebrally injected ova in the CNS. J. Neuroimmunol. 141:90-98.
20. + T cells prevent murine coronavirus spread to the spinal cord and subsequent demyelination. J. Virol. 79:3370-3381.
21. + T-cell epitope to murine coronavirus neurovirulence. J. Virol. 79:9108-9118.
22. Marten, N. W., M. Hohman, S. A. Slohlman, R. D. Atkinson, D. R. Hinton, and C. C. Bergmann. 2001. Acute CNS infection is insufficient to mediate chronic T cell retention. Adv. Exp. Med. Biol. 494:349-354.
23. +-T-cell expansion and trafficking following central nervous system infection. J. Virol. 77:2775-2778.
24. McMahon, E. J., S. L. Bailey, C. V. Castenada, H. Waldner, and S. D. Miller. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11:335-339.
25. + T cells to the brain during Theiler's virus infection. J. Virol. 79:3063-3070.
26. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
27. Navas, S., and S. R. Weiss. 2003. Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropism. J. Virol. 77:4972-4978.
28. Ontiveros, E., T. S. Kim, T. M. Gallagher, and S. Perlman. 2003. Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus strain JHM, is associated with a glycine at residue 310 of the spike glycoprotein. J. Virol. 77:10260-10269.
29. Parra, B., D. R. Hinton, N. W. Marten, C. C. Bergmann, M. T. Lin, C. S. Yang, and S. A. Stohlman. 1999. IFN-γ is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162:1641-1647.
30. Pewe, L., S. B. Heard, C. Bergmann, M. O. Dailey, and S. Perlman. 1999. Selection of CTL escape mutants in mice infected with a neurotropic coronavirus: quantitative estimate of TCR diversity in the infected central nervous system. J. Immunol. 163:6106-6113.
31. Pewe, L., S. Xue, and S. Perlman. 1997. Cytotoxic T-cell-resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus. J. Virol. 71:7640-7647.
32. Phillips, J. J., M. M. Chua, E. Lavi, and S. R. Weiss. 1999. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J. Virol. 73:7752-7760.
33. Phillips, J. J., M. M. Chua, G. F. Rall, and S. R. Weiss. 2002. Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system. Virology 301:109-120.
34. Rempel, J. D., S. J. Murray, J. Meisner, and M. J. Buchmeier. 2004. Differential regulation of innate and adaptive immune responses in viral encephalitis. Virology 318:381-392.
35. Rempel, J. D., S. J. Murray, J. Meisner, and M. J. Buchmeier. 2004. Mouse hepatitis virus neurovirulence: evidence of a linkage between S glycoprotein expression and immunopathology. Virology 318:45-54.
36. San Mateo, L. R., M. M. Chua, S. R. Weiss, and H. Shen. 2002. Perforin-mediated CTL cytolysis counteracts direct cell-cell spread of Listeria monocytogenes. J. Immunol. 169:5202-5208.
37. Sarma, J. D., E. Scheen, S. H. Seo, M. Koval, and S. R. Weiss. 2002. Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system. J. Neurovirol. 8:381-391.
38. Scott, E. P., P. J. Branigan, A. M. Del Vecchio, and S. R. Weiss. 2008. Chemokine expression during mouse hepatitis virus-induced encephalitis: contributions of the spike and background genes. J. Neurovirol. 14:5-16.
39. Shen, H., J. F. Miller, X. Fan, D. Kolwyck, R. Ahmed, and J. T. Harty. 1998. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell 92:535-545.
40. Stohlman, S. A., C. C. Bergmann, R. C. van der Veen, and D. R. Hinton. 1995. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol. 69:684-694.
41. + T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J. Neurovirol. 3:225-228.
42. - dendritic cell maturation and activation following viral infection of the central nervous system: implications for a role in T cell activation. Virology 327:8-15.
43. + cytotoxic T cells in recovery from mouse hepatitis virus infection. Immunology 87:34-41.